GrowBLOX Receives Funding to Complete Construction of Nevada Cultivation Facility
June 15 2015 - 11:51AM
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a biopharmaceutical company
with state-of-the-art technologies in plant biology and cultivation
designed to produce consistent medicinal cannabis, announced here
today that it has received a $1.75 million funding commitment to
enable GrowBLOX to complete construction and set-up operations at
their MME Cultivation Facility in Las Vegas, Nevada. Pacific
Leaf Ventures, LP has provided both the capital infusion and a
license for their intellectual property including recognizable
brand-names of cannabis and proprietary know-how for cultivation
and cannabis extractions.
“This funding represents the final step in a series of
prerequisites for the commencement of operations at our cannabis
cultivation facility in Las Vegas,” said CEO Craig Ellins. He
continued, “Our suite of technologies for tissue culture
propagation of our proprietary strains, growing a safe and
consistent MME product, and efficiently extracting the cannabis
oils will all soon be on display at our state-of-the art facility.
We are also pleased to announce that we have commenced construction
of pre-fab “clean rooms” that we call Cultivation Labs and are
targeting to complete construction of the new Cultivation Facility
by mid-4th quarter in 2015. We believe that our Cultivation
Labs will provide a pristine and consistent environment for growing
and processing medical cannabis that will safeguard our proprietary
technology and equipment, as well as our products. We also
feel that our Cultivation Labs will ensure the security and
integrity of the licenses from Pacific Leaf for its brand name
cannabis strains and products that will be recognized by patients
with reciprocal MME cards in adjacent states like California and
Arizona. We believe that the experience of Pacific Leaf Ventures in
cannabis cultivation and extraction makes our business relationship
potentially far more valuable than any amount of capital
invested.”
About GrowBLOX Sciences,
Inc.
GrowBLOX Sciences, Inc. (OTCQB:GBLX) is a biopharmaceutical
research and development company focused on creating safe,
standardized, pharmaceutical-grade, cannabinoid therapies that
target a variety of medical conditions. The Company has leading
technology and cannabis industry processes, with a “big”
data-driven clinical research and development loop to bring relief
to patients in communities across the country. Through our GBS PR
subsidiary, we are developing and globally distributing our
GrowBLOXTM suite of cultivation and growing chambers. To learn more
about GrowBLOX Sciences, Inc., go to www.gbsciences.com.
Forward-Looking Statements:
This press release may contain statements relating to future
results or events, which are forward-looking statements.
Words such as "expects", "intends", "plans", "may", "could",
"should", "anticipates", "likely", "believes" and words of similar
import may identify forward-looking statements. These statements
are not historical facts, but instead represent only the Company's
belief regarding future events, many of which, by their nature, are
inherently uncertain and outside of the Company's control. It
is possible that the Company's actual results and financial
condition may differ, possibly materially, from the anticipated
results and financial condition indicated in these forward-looking
statements. Further, information concerning the Company and
its business, including factors that potentially could materially
affect the Company's business and financial and other results, are
contained in the Company's filings with the Securities and Exchange
Commission, available at www.sec.gov. All forward-looking
statements included in this press release are made only as of the
date of this press release, and we do not undertake any obligation
to publicly update or correct any forward-looking statements to
reflect events or circumstances that subsequently occur or of which
we hereafter become aware.
Note: Although the Company’s research and
development activities are not illegal, the production and sale of
cannabis products violate federal laws as presently
constituted.
GrowBLOX is a registered trademark of Growblox Sciences,
Inc.
For more Information:
Growblox Sciences, Inc.,
6450 Cameron Street, Suite 110A, Las Vegas, NV 89118
866.721.0297
Craig Ellins, CEO;
Andrea Small Howard, Chief Science Officer.
craig@gbsciences.com
andrea@gbsciences.com
https://gbsciences.com
GB Sciences (PK) (USOTC:GBLX)
Historical Stock Chart
From Mar 2024 to Apr 2024
GB Sciences (PK) (USOTC:GBLX)
Historical Stock Chart
From Apr 2023 to Apr 2024